biotech · Glaucoma · Hepatocellular Carcinoma · AEON
AEON Biopharma
AEON Biopharma is a biotech organization headquartered in irvine, USA. It trades on NYSE under ticker AEON. Primary therapeutic focus areas include Glaucoma, Hepatocellular Carcinoma, Cervical Dystonia, Migraine, Congeni
irvine, USA HQ
11 Employees
Public company Type
AEON · NYSE Ticker
Company details
- Status
- Public
- HQ
- irvine, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 8
- Patents
- 9
autologous ET1402L1-CART cells
Phase 1 · mab · Hepatocellular Carcinoma
autologous ET1402L1-CART cells for Hepatocellular Carcinoma is a Phase 1 program (mab) at AEON Biopharma with 1 ClinicalTrials.gov record(s).
Internal code ETCH17AFPCAR101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- AEON Biopharma
- Phase
- Phase 1
- Modality
- mab
- Indication
- Hepatocellular Carcinoma
- Status
- terminated
- Trials
- 1